2m 2m 2m 2m 2m 2m 2m
NEURAXIS (NRXS)
NYSE
$6.92+$0.04 (+0.51%)
Price as of Jul 13, 2026 7:14 PM EDT- $88.4MMarket Cap
- 177.42%1-Year Change
- BiotechnologyIndustry
NEURAXIS (NRXS)
$6.92+$0.04 (+0.51%)
NRXS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.88 | ||
Change | -$0.26 (-3.64%) | ||
Open | $7.09 | ||
High | $7.30 | ||
Low | $6.88 | ||
Previous Close | $7.14 | ||
Volume | 105,703 | ||
30-Day Average Volume | 81,008 | ||
1-Week Change | -3.91% | ||
1-Month Change | 2.69% | ||
1-Year Change | 177.42% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.4M | ||
Total Assets | $8.7M | ||
Market Cap | $88.4M | ||
Enterprise Value | $81.6M | ||
Period: QTR TTM FY | |||
Revenue | $1.6M | ||
Net Income | -$2.0M | ||
Free Cash Flow | -$1.2M | ||
EBIT | -$1.9M | ||
EBITDA | -$1.9M | ||
Net Working Capital | $5.3M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -43 | ||
Enterprise Value/Revenue | 51 | ||
P/B | 15 | ||
P/E | -40 | ||
PEG | -29 | ||
Price/Free Cash Flow | -72 | ||
Price/Operating Cash Flow | -72 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue